Capitol Trades
TradesPoliticiansIssuersInsightsBuzzPressMoreMore
2023-05-22

Representatives were stocking up as new Pharma Bill makes rounds in Senate

Quiver Quantitative
Quiver Quantitative
@QuiverQuant
·Follow

The Affordable Prescriptions for Patients Act was recently introduced with bipartisan support. It would prevent drug manufacturers from using patents to block generic competition. Here’s what’s going on behind the scenes with corporate lobbying & congressional stock trading 👇

8:12 PM · May 19, 2023
29
Reply
Read 2 replies
Quiver Quantitative
Quiver Quantitative
@QuiverQuant
·Follow
Replying to @QuiverQuant

This is one of the most heavily lobbied pieces of legislation in this session of Congress. Over a dozen publicly traded companies have disclosed lobbying on the bill, including Merck, Pfizer, AstraZeneca, Amgen, Johnson & Johnson, and Eli Lilly.

8:12 PM · May 19, 2023
7
Reply
Read 1 reply
Quiver Quantitative
Quiver Quantitative
@QuiverQuant
·Follow

On March 1st, the bill was placed on the Senate Legislative Calendar. Within a week, two members of the House Ways and Means Subcommittee on Health had bought stock in Johnson & Johnson.

Image
Image
8:12 PM · May 19, 2023
6
Reply
Read 1 reply
Quiver Quantitative
Quiver Quantitative
@QuiverQuant
·Follow
Replying to @QuiverQuant

On April 5th, Representative Michael Burgess bought up to $50K of Amgen stock. Burgess is a member of the House Energy Subcommittee on Health.

Image
8:13 PM · May 19, 2023
5
Reply
Read 1 reply
Quiver Quantitative
Quiver Quantitative
@QuiverQuant
·Follow
Replying to @QuiverQuant

On March 3rd, Representative Carol Miller bought stock in Pfizer. Miller previously served on the House Subcommittee on Economic and Consumer Policy.

Image
8:13 PM · May 19, 2023
7
Reply
Read 1 reply
Back To Buzz

Politician

  • View Profile
  • Kevin Hern

    RepublicanHouseOK
    Trades
    325
    Issuers
    90
    Volume
    33.30M
    • Johnson & Johnson

      JNJ:US
      sell2024-12-31
      100K–250K
    • Johnson & Johnson

      JNJ:US
      buy2024-06-04
      1K–15K
    • Johnson & Johnson

      JNJ:US
      buy2024-03-05
      1K–15K
    • Johnson & Johnson

      JNJ:US
      buy2023-12-05
      1K–15K
    • Johnson & Johnson

      JNJ:US
      buy2023-09-07
      1K–15K

    Related Reading

    • 2025-04-09

      Trump’s Tariff Triggered Turmoil: The Economic & Market Fallout

    • 2025-01-16

      Rep. Gottheimer Makes Waves with $40M in Microsoft Stock Options

    • 2025-01-10

      Capitol Trades 2024 in Review - Markets, Politics & Breakthroughs

    • 2024-12-18

      Rep. Kevin Hern buys $FTV dip, sells $PDRDF to avoid loss

    • 2024-12-10

      Rep. Ro Khanna's trades highlight diversified portfolio moves

    *The historical data available on our website is restricted to the past 3 years.

    *The historical data available on our website is restricted to the past 3 years.

    © 2025 2iQ Research
    Follow About Us Download PressKit Sitemap Privacy Policy Terms & Conditions Imprint Disclaimer

    © 2025 2iQ Research